Use of Human Hybridoma Technology To Isolate Human Monoclonal Antibodies
[color=var(--author-info-color)][size=0.875][color=var(--wiley-blue-color)][size=0.875]Scott A. Smith, [size=0.875]James E. Crowe Jr.
[color=var(--author-info-color)][size=0.875][color=var(--author-info-color)][size=0.875]Book Editor(s):[color=var(--wiley-blue-color)][size=0.875]James E. Crowe Jr., [color=var(--wiley-blue-color)][size=0.875]Diana Boraschi, [color=var(--wiley-blue-color)][size=0.875]Rino Rappuoli
[color=var(--wiley-gray-text-color)][size=0.875][color=var(--wiley-gray-text-color)]First published: [color=var(--wiley-typography-color)]26 May 2015
[size=0.875][color=var(--wiley-blue-color)]https://doi.org/10.1128/9781555817411.ch8
|
10
Exploring the drivers of supply chain sustainability: An internal and external configuration perspective
